Virus News and Research

Latest Virus News and Research

Study investigates people's perceptions of COVID quarantine hotels during pandemic

As vaccination rates continue to rise and government border policies change, the need for hotel quarantine is fading.

21 Jan 2022

Study uncovers clue to why pigs don't get sick when exposed to COVID-19

Iowa State University scientists may have uncovered an important clue that sheds light on why pigs don't get sick when exposed to the coronavirus

20 Jan 2022

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

In their recent study posted to the preprint server bioRxiv*, the researchers from China have shown that tuftsin, a natural phagocytosis-stimulating peptide, can effectively impair the binding of SARS-CoV-2 spike S1 subunit to ACE2 receptor in a dose-dependent manner and therefore can be considered a potential drug against SARS-CoV-2 infection.

20 Jan 2022

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

A recent study looked at the strength, durability and breadth of neutralizing antibody responses generated by breakthrough infections in individuals vaccinated against SARS-CoV2.

20 Jan 2022

Experts highlight the neurological effects of SARS-CoV-2 and the need for rigorous research

SARS-CoV-2 was initially identified as a respiratory virus, but it can affect the entire body, including the nervous system.

20 Jan 2022

Researchers explore furin inhibitors as a potential tool for treating COVID-19 infection

A new study suggests that coronaviruses such as SARS-CoV-2 depend on a furin cleavage site between the S1/S2 subunits to enhance viral infectivity.

20 Jan 2022

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

A new analysis parses out what scientists currently know about the Delta variant and predicts what the end of the COVID-19 pandemic might look like.

20 Jan 2022

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Scientists at Scripps Research have devised a method that may be able to shortcut one of the big steps in modern vaccine development.

20 Jan 2022

RASCL: new analytic pipeline for investigating selective forces acting on viral genes in SARS-CoV-2 sequences

A study revealed a new analytical pipeline to assess the clades of SARS-CoV-2 by molecular sequence analysis.

20 Jan 2022

Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies. The study was published today in Nature Communications.

20 Jan 2022

Development of a glycoprotein multi-epitope subunit vaccine candidate against South-African SARS-CoV-2 strains

In a new study, scientists focused on the SARS-CoV-2 Beta variant and used computational methods to design and develop effective glycoprotein multi-epitope subunit vaccine candidates, based on the old and the new Beta virus strains.

20 Jan 2022

Antibodies to SARS-CoV-2 and infection risk in healthcare workers following mRNA vaccination

A new study aimed to understand the risk of COVID-19 infection given certain serological parameters, in a group of vaccinated healthcare workers with high rates of exposure to the virus, followed up at 9 months from vaccination.

20 Jan 2022

Study simulates transmission of SARS-CoV-2 in airliner cabins

A study published in Indoor Air simulated the transmission of SARS-CoV-2, the virus that causes COVID-19, on a flight from London to Hanoi and on another flight from Singapore to Hangzhou.

20 Jan 2022

Study finds Omicron infection effectively induces immunity against itself and enhances protection against other variants in vaccinated individuals

Researchers investigated the effectiveness of the SARS-CoV-2 Omicron-variant induced immunity, whether it is cross-protective against other variants, and if earlier infection with the SARS-CoV-2 Delta variant offers protection against Omicron.

20 Jan 2022

Recombinant bat coronavirus reported in wide-ranging Cambodian bat

A new study reports on the detection of recombinant coronaviruses in several bat species in Cambodia and of a related species in China.

20 Jan 2022

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

In a new study, researchers discuss the role of calcium signaling pathways as targets of inhibition in potential new antiviral therapeutic pathways for SARS-CoV-2.

20 Jan 2022

The effect of different environmental conditions on the binding behavior of the S protein and RBD of SARS-CoV-2

Researchers investigated the binding behavior of spike protein and receptor-binding domain of SARS-CoV-2 under different environmental conditions.

20 Jan 2022

A novel assay for the rapid detection of SARS-CoV-2 variants

A new study discusses a new assay method designed by researchers to identify SARS-CoV-2 variants.

20 Jan 2022

Virucidal effect of UV and violet light on SARS-CoV-2

In a recent study published in the Journal of Photochemistry and Photobiology, a team of researchers analyzed the effect of ultraviolet (UV) and violet light of different wavelengths on the virulence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

20 Jan 2022

Chatbot helped improve the health of patients whose joint replacement surgeries got delayed by COVID-19

When patients' hip or knee replacements were delayed in response to COVID-19 surges, chatbots delivering encouraging messages not only benefited the mental health of patients – they also experienced boosts to their physical health, too.

20 Jan 2022

Virus News and Research

Latest Virus News and Research

Study investigates people's perceptions of COVID quarantine hotels during pandemic

Study uncovers clue to why pigs don't get sick when exposed to COVID-19

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

Experts highlight the neurological effects of SARS-CoV-2 and the need for rigorous research

Researchers explore furin inhibitors as a potential tool for treating COVID-19 infection

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

New cryo-EM method may be able to shortcut a big step in modern vaccine development

RASCL: new analytic pipeline for investigating selective forces acting on viral genes in SARS-CoV-2 sequences

Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Development of a glycoprotein multi-epitope subunit vaccine candidate against South-African SARS-CoV-2 strains

Antibodies to SARS-CoV-2 and infection risk in healthcare workers following mRNA vaccination

Study simulates transmission of SARS-CoV-2 in airliner cabins

Study finds Omicron infection effectively induces immunity against itself and enhances protection against other variants in vaccinated individuals

Recombinant bat coronavirus reported in wide-ranging Cambodian bat

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

The effect of different environmental conditions on the binding behavior of the S protein and RBD of SARS-CoV-2

A novel assay for the rapid detection of SARS-CoV-2 variants

Virucidal effect of UV and violet light on SARS-CoV-2

Chatbot helped improve the health of patients whose joint replacement surgeries got delayed by COVID-19

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in